three-day activated cll b cells compared with activated control b cells demonstrated a marked impairment in their ability to absorb out the bcgf activity present in the bcgf preparation ( bcgf activity absorbed out , patient 12.8 % v control 53 % ) .
C0023434
cll
C0004561
b